Pre-clinical study of 21 approved drugs in the mdx mouse (Q54605554)

1 June 2018

title

Pre-clinical study of 21 approved drugs in the mdx mouse (English)

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

27 November 2024

author name string

Maïté Carre-Pierrat

1

1 reference

1 June 2018

Aude Lafoux

2

1 reference

1 June 2018

Guillaume Tanniou

3

1 reference

1 June 2018

Lucie Chambonnier

4

1 reference

1 June 2018

Alexandra Divet

5

1 reference

1 June 2018

Francoise Fougerousse

6

1 reference

1 June 2018

Corinne Huchet-Cadiou

7

1 reference

1 June 2018

Laurent Ségalat

8

1 reference

1 June 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21392993

27 November 2024

publication date

9 March 2011

1 reference

1 June 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0960896611000071?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

https://api.elsevier.com/content/article/PII:S0960896611000071?httpAccept=text/plain

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

27 November 2024

published in

Neuromuscular Disorders

1 reference

1 June 2018

volume

21

1 reference

1 June 2018

issue

5

1 reference

1 June 2018

page(s)

313-327

1 reference

1 June 2018

Function and genetics of dystrophin and dystrophin-related proteins in muscle

cites work

2

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Pathophysiology of duchenne muscular dystrophy: current hypotheses

27 November 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Pharmacological strategies for muscular dystrophy

27 November 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

The role of corticosteroids in muscular dystrophy: a critical appraisal

27 November 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Glucocorticoid corticosteroids for Duchenne muscular dystrophy

27 November 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Gene therapy for muscular dystrophy: current progress and future prospects.

27 November 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Gene therapy in large animal models of muscular dystrophy

27 November 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Prednisone reduces muscle degeneration in dystrophin-deficient Caenorhabditis elegans

27 November 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Blocking of striated muscle degeneration by serotonin in C. elegans

27 November 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Dose translation from animal to human studies revisited

27 November 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Consequence of parvalbumin deficiency in the mdx mouse: histological, biochemical and mechanical phenotype of a new double mutant.

27 November 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Fetal muscle-derived cells can repair dystrophic muscles in mdx mice.

27 November 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Sarcoplasmic reticulum function in slow- and fast-twitch skeletal muscles from mdx mice

27 November 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Greater susceptibility of the sarcoplasmic reticulum to H2O2 injuries in diaphragm muscle from mdx mice

27 November 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Effects of cyclopiazonic acid on Ca(2 )-activated tension production in skinned skeletal muscle fibres of the ferret

27 November 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Contractile properties of skinned muscle fibres from young and adult normal and dystrophic (mdx) mice

27 November 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Changes of intracellular milieu with fatigue or hypoxia depress contraction of skinned rabbit skeletal and cardiac muscle

27 November 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

A noninvasive procedure to detect muscle weakness in the mdx mouse

27 November 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Effect of nitric oxide on the maximal velocity of shortening of a mouse skeletal muscle

27 November 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Consequences of the combined deficiency in dystrophin and utrophin on the mechanical properties and myosin composition of some limb and respiratory muscles of the mouse.

27 November 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch

27 November 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Prednisone in dystrophin-deficient Caernorabditis elegans

27 November 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Drug discovery: here comes the worm

27 November 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy

27 November 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

The mode of neuromuscular blocking action of chlorpromazine

27 November 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

The effect of imipramine on isolated skeletal muscle preparations

27 November 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Proximal myopathy induced by 5-HT-imipramine simulates Duchenne dystrophy

27 November 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Skeletal muscle necrosis following membrane-active drugs plus serotonin

27 November 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Molecular mechanisms of inhibition of nicotinic acetylcholine receptors by tricyclic antidepressants

27 November 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Antagonism of nicotinic acetylcholine receptors by inhibitors of monoamine uptake.

27 November 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Tricyclic antidepressant amitriptyline alters sarcoplasmic reticulum calcium handling in ventricular myocytes

27 November 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Clomipramine and related structures as inhibitors of the skeletal sarcoplasmic reticulum Ca2 pump

27 November 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Amitriptyline activates cardiac ryanodine channels and causes spontaneous sarcoplasmic reticulum calcium release

27 November 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Biochemical localisation of the 5-HT2A (serotonin) receptor in rat skeletal muscle

27 November 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Identification and localization of a skeletal muscle secrotonin 5-HT2A receptor coupled to the Jak/STAT pathway

27 November 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Ritanserin attenuates the in vitro effects of the 5-HT2 receptor agonist DOI on skeletal muscles from malignant hyperthermia-susceptible patients

27 November 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Tricyclic Antidepressant Poisoning

27 November 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Elevated subsarcolemmal Ca2 in mdx mouse skeletal muscle fibers detected with Ca2 -activated K channels.

27 November 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

The skeletal L-type Ca(2 ) current is a major contributor to excitation-coupled Ca(2 ) entry

27 November 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Calcium antagonists for Duchenne muscular dystrophy

27 November 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Vasodilating effects of tetrazepam in isolated vascular smooth muscles: comparison with cromakalim and diltiazem

27 November 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Hindlimb immobilization applied to 21-day-old mdx mice prevents the occurrence of muscle degeneration

27 November 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Dystrophin-dependent muscle degeneration requires a fully functional contractile machinery to occur in C. elegans

27 November 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.

27 November 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: outcome of a large array of in vivo and ex vivo tests.

27 November 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

Evaluation of potential synergistic action of a combined treatment with alpha-methyl-prednisolone and taurine on the mdx mouse model of Duchenne muscular dystrophy.

27 November 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2011.01.005

27 November 2024

Identifiers

1 reference

1 June 2018

1 reference

1 June 2018